233
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Incident diabetes complications among women with type 1 diabetes based on parity

, , , , , , , , & show all
Pages 4629-4634 | Received 29 Jan 2020, Accepted 27 Nov 2020, Published online: 06 Dec 2020

References

  • Kitzmiller JL, Block JM, Brown FM, et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care. 2008;31(5):1060–1079.
  • Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ. 2004;328(7445):915.
  • Morrison JL, Hodgson LA, Lim LL, et al. Diabetic retinopathy in pregnancy: a review. Clin Exp Ophthalmol. 2016;44(4):321–334.
  • Behrens I, Basit S, Melbye M, et al. Risk of post-pregnancy hypertension in women with a history of hypertensive disorders of pregnancy: nationwide cohort study. BMJ. 2017;358:j3078.
  • Ray JG, Vermeulen MJ, Schull MJ, et al. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet. 2005;366(9499):1797–1803.
  • Azzoug S, Chentli F. Microangiopathy and pregnancy. J Pak Med Assoc. 2016;66(9 Suppl 1):S52–S55.
  • Rossing K, Jacobsen P, Hommel E, et al. Pregnancy and progression of diabetic nephropathy. Diabetologia. 2002;45(1):36–41.
  • Wang IK, Muo CH, Chang YC, et al. Association between hypertensive disorders during pregnancy and end-stage renal disease: a population-based study. CMAJ. 2013;185(3):207–213.
  • Wu CC, Chen SH, Ho CH, et al. End-stage renal disease after hypertensive disorders in pregnancy. Am J Obstet Gynecol. 2014;210(2):147 e1–147 e8.
  • Lloyd CE, Kuller LH, Ellis D, et al. Coronary artery disease in IDDM. Gender differences in risk factors but not risk. Arterioscler Thromb Vasc Biol. 1996;16(6):720–726.
  • Maric-Bilkan C. Sex differences in micro- and macro-vascular complications of diabetes mellitus. Clin Sci (Lond). 2017;131(9):833–846.
  • Shah VN, Wu M, Polsky S, et al. Gender differences in diabetes self-care in adults with type 1 diabetes: findings from the T1D Exchange clinic registry. J Diabetes Complications. 2018;32(10):961–965.
  • Herrera E, Ortega-Senovilla H. Lipid metabolism during pregnancy and its implications for fetal growth. Curr Pharm Biotechnol. 2014;15(1):24–31.
  • Wang J, Li Z, Lin L. Maternal lipid profiles in women with and without gestational diabetes mellitus. Medicine (Baltimore). 2019;98(16):e15320.
  • Gobl CS, Handisurya A, Klein K, et al. Changes in serum lipid levels during pregnancy in type 1 and type 2 diabetic subjects. Diabetes Care. 2010;33(9):2071–2073.
  • Schaefer-Graf UM, Meitzner K, Ortega-Senovilla H, et al. Differences in the implications of maternal lipids on fetal metabolism and growth between gestational diabetes mellitus and control pregnancies. Diabet Med. 2011;28(9):1053–1059.
  • Beck RW, Tamborlane WV, Bergenstal RM, et al. The T1D Exchange clinic registry. J Clin Endocrinol Metab. 2012;97(12):4383–4389.
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
  • Miller M, Stone NJ, Ballantyne C, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123(20):2292–2333.
  • Centers for Disease Control and Prevention. Z-score data files 2013. Available from: http://www.cdc.gov/growthcharts/zscore.htm.
  • Jousilahti P, Vartiainen E, Tuomilehto J, et al. Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation. 1999;99(9):1165–1172.
  • Hill B, Bergmeier H, McPhie S, et al. Is parity a risk factor for excessive weight gain during pregnancy and postpartum weight retention? A systematic review and meta-analysis. Obes Rev. 2017;18(7):755–764.
  • Costacou T, Orchard TJ. Cumulative kidney complication risk by 50 years of type 1 diabetes: the effects of sex, age, and calendar year at onset. Diabetes Care. 2018;41(3):426–433. Mar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.